Table of Content

1 Fibromyalgia Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Fibromyalgia Therapeutics Drugs
1.2 Fibromyalgia Therapeutics Drugs Segment by Type
1.2.1 Global Fibromyalgia Therapeutics Drugs Market Value Comparison by Type (2024-2034)
1.2.2 Cymbalta (Duloxetine)
1.2.3 Savella (Milnacipran)
1.2.4 Lyrica (Pregabalin)
1.2.5 Pancuronium
1.2.6 Others
1.3 Fibromyalgia Therapeutics Drugs Segment by Application
1.3.1 Global Fibromyalgia Therapeutics Drugs Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Fibromyalgia Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Fibromyalgia Therapeutics Drugs Revenue 2018-2034
1.4.2 Global Fibromyalgia Therapeutics Drugs Sales 2018-2034
1.4.3 Global Fibromyalgia Therapeutics Drugs Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Fibromyalgia Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2018-2024)
2.2 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Fibromyalgia Therapeutics Drugs Average Price by Manufacturers (2018-2024)
2.4 Global Fibromyalgia Therapeutics Drugs Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Fibromyalgia Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fibromyalgia Therapeutics Drugs, Product Type & Application
2.7 Fibromyalgia Therapeutics Drugs Market Competitive Situation and Trends
2.7.1 Fibromyalgia Therapeutics Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fibromyalgia Therapeutics Drugs Players Market Share by Revenue
2.7.3 Global Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fibromyalgia Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Fibromyalgia Therapeutics Drugs Market Size by Region: 2018 Versus 2022 Versus 2034
3.2 Global Fibromyalgia Therapeutics Drugs Global Fibromyalgia Therapeutics Drugs Sales by Region: 2018-2034
3.2.1 Global Fibromyalgia Therapeutics Drugs Sales by Region: 2018-2024
3.2.2 Global Fibromyalgia Therapeutics Drugs Sales by Region: 2024-2034
3.3 Global Fibromyalgia Therapeutics Drugs Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2018-2034
3.3.1 Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2018-2024
3.3.2 Global Fibromyalgia Therapeutics Drugs Revenue by Region: 2024-2034
3.4 North America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Fibromyalgia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.4.2 North America Fibromyalgia Therapeutics Drugs Sales by Country (2018-2034)
3.4.3 North America Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Fibromyalgia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.5.2 Europe Fibromyalgia Therapeutics Drugs Sales by Country (2018-2034)
3.5.3 Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Fibromyalgia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.6.2 Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Country (2018-2034)
3.6.3 Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Fibromyalgia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.7.2 Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2018-2034)
3.7.3 Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Fibromyalgia Therapeutics Drugs Market Size by Country: 2018 VS 2022 VS 2034
3.8.2 Middle East and Africa Fibromyalgia Therapeutics Drugs Sales by Country (2018-2034)
3.8.3 Middle East and Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fibromyalgia Therapeutics Drugs Sales by Type (2018-2034)
4.1.1 Global Fibromyalgia Therapeutics Drugs Sales by Type (2018-2024)
4.1.2 Global Fibromyalgia Therapeutics Drugs Sales by Type (2024-2034)
4.1.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2018-2034)
4.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2018-2034)
4.2.1 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2018-2024)
4.2.2 Global Fibromyalgia Therapeutics Drugs Revenue by Type (2024-2034)
4.2.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2018-2034)
4.3 Global Fibromyalgia Therapeutics Drugs Price by Type (2018-2034)
5 Segment by Application
5.1 Global Fibromyalgia Therapeutics Drugs Sales by Application (2018-2034)
5.1.1 Global Fibromyalgia Therapeutics Drugs Sales by Application (2018-2024)
5.1.2 Global Fibromyalgia Therapeutics Drugs Sales by Application (2024-2034)
5.1.3 Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2018-2034)
5.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2018-2034)
5.2.1 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2018-2024)
5.2.2 Global Fibromyalgia Therapeutics Drugs Revenue by Application (2024-2034)
5.2.3 Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2018-2034)
5.3 Global Fibromyalgia Therapeutics Drugs Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Pfizer Fibromyalgia Therapeutics Drugs Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Eli Lilly
6.2.1 Eli Lilly Corporation Information
6.2.2 Eli Lilly Description and Business Overview
6.2.3 Eli Lilly Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.2.4 Eli Lilly Fibromyalgia Therapeutics Drugs Product Portfolio
6.2.5 Eli Lilly Recent Developments/Updates
6.3 Actavis
6.3.1 Actavis Corporation Information
6.3.2 Actavis Description and Business Overview
6.3.3 Actavis Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Actavis Fibromyalgia Therapeutics Drugs Product Portfolio
6.3.5 Actavis Recent Developments/Updates
6.4 Merck Sharp and Dohme
6.4.1 Merck Sharp and Dohme Corporation Information
6.4.2 Merck Sharp and Dohme Description and Business Overview
6.4.3 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product Portfolio
6.4.5 Merck Sharp and Dohme Recent Developments/Updates
6.5 Daiichi Sankyo
6.5.1 Daiichi Sankyo Corporation Information
6.5.2 Daiichi Sankyo Description and Business Overview
6.5.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
6.5.5 Daiichi Sankyo Recent Developments/Updates
6.6 Innovative Med Concepts
6.6.1 Innovative Med Concepts Corporation Information
6.6.2 Innovative Med Concepts Description and Business Overview
6.6.3 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product Portfolio
6.6.5 Innovative Med Concepts Recent Developments/Updates
6.7 Meda
6.6.1 Meda Corporation Information
6.6.2 Meda Description and Business Overview
6.6.3 Meda Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Meda Fibromyalgia Therapeutics Drugs Product Portfolio
6.7.5 Meda Recent Developments/Updates
6.8 Meiji Seika
6.8.1 Meiji Seika Corporation Information
6.8.2 Meiji Seika Description and Business Overview
6.8.3 Meiji Seika Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Meiji Seika Fibromyalgia Therapeutics Drugs Product Portfolio
6.8.5 Meiji Seika Recent Developments/Updates
6.9 Switch Biotech
6.9.1 Switch Biotech Corporation Information
6.9.2 Switch Biotech Description and Business Overview
6.9.3 Switch Biotech Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Switch Biotech Fibromyalgia Therapeutics Drugs Product Portfolio
6.9.5 Switch Biotech Recent Developments/Updates
6.10 Theravance
6.10.1 Theravance Corporation Information
6.10.2 Theravance Description and Business Overview
6.10.3 Theravance Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Theravance Fibromyalgia Therapeutics Drugs Product Portfolio
6.10.5 Theravance Recent Developments/Updates
6.11 Zynerba Pharmaceuticals
6.11.1 Zynerba Pharmaceuticals Corporation Information
6.11.2 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Description and Business Overview
6.11.3 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product Portfolio
6.11.5 Zynerba Pharmaceuticals Recent Developments/Updates
6.12 Tonix Pharmaceuticals Holding Corp. (TNXP)
6.12.1 Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
6.12.2 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Description and Business Overview
6.12.3 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.12.4 Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product Portfolio
6.12.5 Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments/Updates
6.13 Daiichi Sankyo
6.13.1 Daiichi Sankyo Corporation Information
6.13.2 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Description and Business Overview
6.13.3 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.13.4 Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product Portfolio
6.13.5 Daiichi Sankyo Recent Developments/Updates
6.14 Forest Pharmaceuticals, Inc.
6.14.1 Forest Pharmaceuticals, Inc. Corporation Information
6.14.2 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Description and Business Overview
6.14.3 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.14.4 Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product Portfolio
6.14.5 Forest Pharmaceuticals, Inc. Recent Developments/Updates
6.15 Boehringer Ingelheim GmbH
6.15.1 Boehringer Ingelheim GmbH Corporation Information
6.15.2 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Description and Business Overview
6.15.3 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.15.4 Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product Portfolio
6.15.5 Boehringer Ingelheim GmbH Recent Developments/Updates
6.16 Pierre Fabre Mdicament
6.16.1 Pierre Fabre Mdicament Corporation Information
6.16.2 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Description and Business Overview
6.16.3 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales, Revenue and Gross Margin (2018-2024)
6.16.4 Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product Portfolio
6.16.5 Pierre Fabre Mdicament Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fibromyalgia Therapeutics Drugs Industry Chain Analysis
7.2 Fibromyalgia Therapeutics Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fibromyalgia Therapeutics Drugs Production Mode & Process
7.4 Fibromyalgia Therapeutics Drugs Sales and Marketing
7.4.1 Fibromyalgia Therapeutics Drugs Sales Channels
7.4.2 Fibromyalgia Therapeutics Drugs Distributors
7.5 Fibromyalgia Therapeutics Drugs Customers
8 Fibromyalgia Therapeutics Drugs Market Dynamics
8.1 Fibromyalgia Therapeutics Drugs Industry Trends
8.2 Fibromyalgia Therapeutics Drugs Market Drivers
8.3 Fibromyalgia Therapeutics Drugs Market Challenges
8.4 Fibromyalgia Therapeutics Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Fibromyalgia Therapeutics Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Fibromyalgia Therapeutics Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Fibromyalgia Therapeutics Drugs Market Competitive Situation by Manufacturers in 2022
Table 4. Global Fibromyalgia Therapeutics Drugs Sales (Kg) of Key Manufacturers (2018-2024)
Table 5. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Fibromyalgia Therapeutics Drugs Average Price (USD/g) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Fibromyalgia Therapeutics Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Fibromyalgia Therapeutics Drugs, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Fibromyalgia Therapeutics Drugs, Product Type & Application
Table 12. Global Key Manufacturers of Fibromyalgia Therapeutics Drugs, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Fibromyalgia Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fibromyalgia Therapeutics Drugs as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Fibromyalgia Therapeutics Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Table 17. Global Fibromyalgia Therapeutics Drugs Sales by Region (2018-2024) & (Kg)
Table 18. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2018-2024)
Table 19. Global Fibromyalgia Therapeutics Drugs Sales by Region (2024-2034) & (Kg)
Table 20. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2024-2034)
Table 21. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2018-2024)
Table 23. Global Fibromyalgia Therapeutics Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2024-2034)
Table 25. North America Fibromyalgia Therapeutics Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 26. North America Fibromyalgia Therapeutics Drugs Sales by Country (2018-2024) & (Kg)
Table 27. North America Fibromyalgia Therapeutics Drugs Sales by Country (2024-2034) & (Kg)
Table 28. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Fibromyalgia Therapeutics Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Fibromyalgia Therapeutics Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 31. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2018-2024) & (Kg)
Table 32. Europe Fibromyalgia Therapeutics Drugs Sales by Country (2024-2034) & (Kg)
Table 33. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Fibromyalgia Therapeutics Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 36. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2018-2024) & (Kg)
Table 37. Asia Pacific Fibromyalgia Therapeutics Drugs Sales by Region (2024-2034) & (Kg)
Table 38. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 41. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2018-2024) & (Kg)
Table 42. Latin America Fibromyalgia Therapeutics Drugs Sales by Country (2024-2034) & (Kg)
Table 43. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Fibromyalgia Therapeutics Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 46. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Country (2018-2024) & (Kg)
Table 47. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales by Country (2024-2034) & (Kg)
Table 48. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Type (2018-2024)
Table 51. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Type (2024-2034)
Table 52. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2018-2024)
Table 53. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Type (2024-2034)
Table 54. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2018-2024)
Table 57. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Type (2024-2034)
Table 58. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Type (2018-2024)
Table 59. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Type (2024-2034)
Table 60. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Application (2018-2024)
Table 61. Global Fibromyalgia Therapeutics Drugs Sales (Kg) by Application (2024-2034)
Table 62. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2018-2024)
Table 63. Global Fibromyalgia Therapeutics Drugs Sales Market Share by Application (2024-2034)
Table 64. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Fibromyalgia Therapeutics Drugs Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2018-2024)
Table 67. Global Fibromyalgia Therapeutics Drugs Revenue Market Share by Application (2024-2034)
Table 68. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Application (2018-2024)
Table 69. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 73. Pfizer Fibromyalgia Therapeutics Drugs Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Eli Lilly Corporation Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 78. Eli Lilly Fibromyalgia Therapeutics Drugs Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Actavis Corporation Information
Table 81. Actavis Description and Business Overview
Table 82. Actavis Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 83. Actavis Fibromyalgia Therapeutics Drugs Product
Table 84. Actavis Recent Developments/Updates
Table 85. Merck Sharp and Dohme Corporation Information
Table 86. Merck Sharp and Dohme Description and Business Overview
Table 87. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 88. Merck Sharp and Dohme Fibromyalgia Therapeutics Drugs Product
Table 89. Merck Sharp and Dohme Recent Developments/Updates
Table 90. Daiichi Sankyo Corporation Information
Table 91. Daiichi Sankyo Description and Business Overview
Table 92. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 93. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product
Table 94. Daiichi Sankyo Recent Developments/Updates
Table 95. Innovative Med Concepts Corporation Information
Table 96. Innovative Med Concepts Description and Business Overview
Table 97. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 98. Innovative Med Concepts Fibromyalgia Therapeutics Drugs Product
Table 99. Innovative Med Concepts Recent Developments/Updates
Table 100. Meda Corporation Information
Table 101. Meda Description and Business Overview
Table 102. Meda Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 103. Meda Fibromyalgia Therapeutics Drugs Product
Table 104. Meda Recent Developments/Updates
Table 105. Meiji Seika Corporation Information
Table 106. Meiji Seika Description and Business Overview
Table 107. Meiji Seika Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 108. Meiji Seika Fibromyalgia Therapeutics Drugs Product
Table 109. Meiji Seika Recent Developments/Updates
Table 110. Switch Biotech Corporation Information
Table 111. Switch Biotech Description and Business Overview
Table 112. Switch Biotech Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 113. Switch Biotech Fibromyalgia Therapeutics Drugs Product
Table 114. Switch Biotech Recent Developments/Updates
Table 115. Theravance Corporation Information
Table 116. Theravance Description and Business Overview
Table 117. Theravance Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 118. Theravance Fibromyalgia Therapeutics Drugs Product
Table 119. Theravance Recent Developments/Updates
Table 120. Zynerba Pharmaceuticals Corporation Information
Table 121. Zynerba Pharmaceuticals Description and Business Overview
Table 122. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 123. Zynerba Pharmaceuticals Fibromyalgia Therapeutics Drugs Product
Table 124. Zynerba Pharmaceuticals Recent Developments/Updates
Table 125. Tonix Pharmaceuticals Holding Corp. (TNXP) Corporation Information
Table 126. Tonix Pharmaceuticals Holding Corp. (TNXP) Description and Business Overview
Table 127. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 128. Tonix Pharmaceuticals Holding Corp. (TNXP) Fibromyalgia Therapeutics Drugs Product
Table 129. Tonix Pharmaceuticals Holding Corp. (TNXP) Recent Developments/Updates
Table 130. Daiichi Sankyo Corporation Information
Table 131. Daiichi Sankyo Description and Business Overview
Table 132. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 133. Daiichi Sankyo Fibromyalgia Therapeutics Drugs Product
Table 134. Daiichi Sankyo Recent Developments/Updates
Table 135. Forest Pharmaceuticals, Inc. Corporation Information
Table 136. Forest Pharmaceuticals, Inc. Description and Business Overview
Table 137. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 138. Forest Pharmaceuticals, Inc. Fibromyalgia Therapeutics Drugs Product
Table 139. Forest Pharmaceuticals, Inc. Recent Developments/Updates
Table 140. Boehringer Ingelheim GmbH Corporation Information
Table 141. Boehringer Ingelheim GmbH Description and Business Overview
Table 142. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 143. Boehringer Ingelheim GmbH Fibromyalgia Therapeutics Drugs Product
Table 144. Boehringer Ingelheim GmbH Recent Developments/Updates
Table 145. Pierre Fabre Mdicament Corporation Information
Table 146. Pierre Fabre Mdicament Description and Business Overview
Table 147. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2018-2024)
Table 148. Pierre Fabre Mdicament Fibromyalgia Therapeutics Drugs Product
Table 149. Pierre Fabre Mdicament Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Fibromyalgia Therapeutics Drugs Distributors List
Table 153. Fibromyalgia Therapeutics Drugs Customers List
Table 154. Fibromyalgia Therapeutics Drugs Market Trends
Table 155. Fibromyalgia Therapeutics Drugs Market Drivers
Table 156. Fibromyalgia Therapeutics Drugs Market Challenges
Table 157. Fibromyalgia Therapeutics Drugs Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Fibromyalgia Therapeutics Drugs
Figure 2. Global Fibromyalgia Therapeutics Drugs Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Fibromyalgia Therapeutics Drugs Market Share by Type in 2022 & 2034
Figure 4. Cymbalta (Duloxetine) Product Picture
Figure 5. Savella (Milnacipran) Product Picture
Figure 6. Lyrica (Pregabalin) Product Picture
Figure 7. Pancuronium Product Picture
Figure 8. Others Product Picture
Figure 9. Global Fibromyalgia Therapeutics Drugs Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Fibromyalgia Therapeutics Drugs Market Share by Application in 2022 & 2034
Figure 11. Hospital
Figure 12. Clinic
Figure 13. Others
Figure 14. Global Fibromyalgia Therapeutics Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 15. Global Fibromyalgia Therapeutics Drugs Market Size (2018-2034) & (US$ Million)
Figure 16. Global Fibromyalgia Therapeutics Drugs Sales (2018-2034) & (Kg)
Figure 17. Global Fibromyalgia Therapeutics Drugs Average Price (USD/g) & (2018-2034)
Figure 18. Fibromyalgia Therapeutics Drugs Report Years Considered
Figure 19. Fibromyalgia Therapeutics Drugs Sales Share by Manufacturers in 2022
Figure 20. Global Fibromyalgia Therapeutics Drugs Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Fibromyalgia Therapeutics Drugs Players: Market Share by Revenue in 2022
Figure 22. Fibromyalgia Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Fibromyalgia Therapeutics Drugs Market Size by Region (US$ Million): 2018 VS 2022 VS 2034
Figure 24. North America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2018-2034)
Figure 25. North America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2018-2034)
Figure 26. U.S. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. Canada Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. Europe Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2018-2034)
Figure 29. Europe Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2018-2034)
Figure 30. Germany Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. France Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. U.K. Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Italy Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Russia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Asia Pacific Fibromyalgia Therapeutics Drugs Sales Market Share by Region (2018-2034)
Figure 36. Asia Pacific Fibromyalgia Therapeutics Drugs Revenue Market Share by Region (2018-2034)
Figure 37. China Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Japan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. South Korea Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. India Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Australia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Taiwan Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Indonesia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Thailand Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Malaysia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Philippines Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Latin America Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2018-2034)
Figure 48. Latin America Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2018-2034)
Figure 49. Mexico Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Brazil Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Argentina Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Middle East & Africa Fibromyalgia Therapeutics Drugs Sales Market Share by Country (2018-2034)
Figure 53. Middle East & Africa Fibromyalgia Therapeutics Drugs Revenue Market Share by Country (2018-2034)
Figure 54. Turkey Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Saudi Arabia Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 56. UAE Fibromyalgia Therapeutics Drugs Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 57. Global Sales Market Share of Fibromyalgia Therapeutics Drugs by Type (2018-2034)
Figure 58. Global Revenue Market Share of Fibromyalgia Therapeutics Drugs by Type (2018-2034)
Figure 59. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Type (2018-2034)
Figure 60. Global Sales Market Share of Fibromyalgia Therapeutics Drugs by Application (2018-2034)
Figure 61. Global Revenue Market Share of Fibromyalgia Therapeutics Drugs by Application (2018-2034)
Figure 62. Global Fibromyalgia Therapeutics Drugs Price (USD/g) by Application (2018-2034)
Figure 63. Fibromyalgia Therapeutics Drugs Value Chain
Figure 64. Fibromyalgia Therapeutics Drugs Production Process
Figure 65. Channels of Distribution (Direct Vs Distribution)
Figure 66. Distributors Profiles
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed